z-logo
open-access-imgOpen Access
S0892 Cost-Effectiveness Analysis: Adjuvanted Hepatitis B Vaccine (HEPLISAV-B™) in Patients With Inflammatory Bowel Disease
Author(s) -
Juan E. Corral,
Joshua Kwon,
Freddy Caldera,
Surakit Pungpapong,
Aaron Spaulding,
Bijan J. Borah,
James P. Moriarty,
Francis A. Farraye
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705616.81183.3b
Subject(s) - medicine , cohort , hepatitis b , hepatitis b virus , vaccination , cirrhosis , inflammatory bowel disease , gastroenterology , immunology , disease , virus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here